Why the study?
It is unknown how cancer survivors who underwent cardiotoxic therapies should be monitored, prompting investigation into their prevalence, long-term survival, and cardiovascular outcomes among patients presenting with chest pain for CTA.
Does a history of malignancy affect long-term survival and cardiovascular outcomes in patients with chest pain referred for computed tomography angiography?
Population
1,892 patients with chest pain who underwent computed tomography angiography
Comparison
History of malignancy vs no history of malignancy
Design
Observational cohort study
Follow-up
ten years
Authors
Loading...
Higher mortality and CAC in cancer survivors referred for CTA warrant caution in monitoring; leaves open optimal surveillance strategies.
Does a history of malignancy affect long-term survival and cardiovascular outcomes in patients with chest pain referred for computed tomography angiography?
In patients with chest pain referred for CTA, a history of malignancy is associated with higher long-term mortality, higher CAC percentiles, and more incidental malignancies, but not with an increased prevalence of obstructive CAD.
Sharma et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: